The Effect of Intensive Treatment of Diabetes on the Development of Retinopathy

Abstract

Diabetic retinopathy (DR) is one of the most common microvascular complications of diabetes and a leading cause of blindness among adults. Intensive management of diabetes, particularly tight blood glucose control, has been shown to significantly impact the development and progression of diabetic retinopathy. Several landmark studies, such as the Diabetes Control and Complications Trial (DCCT) and the United Kingdom Prospective Diabetes Study (UKPDS), have demonstrated that tight glycemic control can reduce the incidence of DR in type 1 and type 2 diabetes, respectively. In these studies, intensive treatment strategies, including near-normal blood glucose levels, were associated with a significant reduction in both the onset and progression of diabetic retinopathy. However, challenges such as patient adherence to treatment regimens, hypoglycemia, and the complexity of long-term management persist. This review highlights the evidence supporting intensive treatment of diabetes and its effect on retinopathy development. It also discusses the practical implications and challenges of applying intensive diabetes management in everyday clinical practice. While intensive glucose control is beneficial, further research is needed to identify optimal strategies for long-term management and to improve accessibility to effective treatments.

Keywords: Diabetes, intensive treatment, retinopathy, blood glucose control, diabetic retinopathy, clinical trials, type 1 diabetes, type 2 diabetes.